Open long · week 15
Vertex Pharmaceuticals drops 4.1% and closes below its Inversion Point, in the 510 area
Our view last week
After 4 weeks with sellers in charge, buyers took back 90% of the volume on Vertex Pharmaceuticals stock and the week closed up 3.5%. On the daily chart the price bounced off its 20-day moving average, in the 522 area. Technical analysis still calls for caution: money flow is rising but stays below zero, the MACD is losing steam and weekly price action still points to distribution. For swing trading purposes, the trade remains up 16.5% from entry.
This week's summary
Vertex Pharmaceuticals stock fell 4.1% and handed back all of last week's rebound: the 20-day moving average is lost again and the week printed a new 30-day low, in the 500 area, that the close did not confirm. Technical analysis shows money flow negative for 5 weeks and the MACD histogram falling for 4. For swing trading purposes, the trade is still up 11.76% from entry. Price closed below the second stop level (SL2) flagged in last week's card (509.71 area): for anyone following that level the trade is closed. The close and the Inversion Point, in the 510 area, have already crossed with no change of sign declared: one to watch in the coming sessions.
IQS Phase
53
ordinary
Signal Strength
70
high · wide move
Sizing
FULL
Ranking
#21 / 93
US stocks in progress
Trade P&L %
+11.76%
from signal to date, no stop loss
Vertex Pharmaceuticals (VRTX) weekly chart — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
Rank position
ranks 21st among the 93 Longs already running for US stocks in our ranking, with a signal strength of 70 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -2.65% · monthly -3.91%
VRTX belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content